Peter Vandenabeele
Gent, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 273 publications
Author Correction: Quantifying single-cell ERK dynamics in colorectal cancer organoids reveals EGFR as an amplifier of oncogenic MAPK pathway signalling.
Journal: Nature cell biology
Published: July 31, 2026
Neuronal Cell Death Modalities and Protective Mechanisms Induced By Sevoflurane: A Narrative Review.
Neuronal Cell Death Modalities and Protective Mechanisms Induced By Sevoflurane: A Narrative Review.
Journal: Anesthesia and analgesia
Published: May 06, 2026
Caspase-3/7 deficiency results in enhanced intestinal inflammation and reduced tumorigenesis.
Journal: Science advances
Published: March 20, 2026
PAD4-generated citrullinated histones are triggers for autoinflammation in cryopyrin-associated periodic syndrome.
Journal: Cell death and differentiation
Published: January 28, 2026
Identification of small-molecule autophagy activators via GFP-LC3 high-throughput screening and a cargo-based autophagy flux and processing assay.
Journal: European journal of pharmacology
Published: January 12, 2026
For Better or Worse: The Impact of Necrotic Cell Death Modalities.
Journal: Advances in experimental medicine and biology
Published: September 26, 2025
Author Correction: Targeting ferroptosis protects against experimental (multi)organ dysfunction and death.
Journal: Nature communications
Published: September 18, 2025
Applicability of Raman Spectroscopy for the Assessment of Wheat Flour Quality and Functionality in Bakery Applications.
Journal: Foods (Basel, Switzerland)
Published: August 21, 2025
Structural and mechanistic insights into the constitutive Themis-Grb2 complex in T cell signalling.
Journal: Nature communications
Published: April 18, 2025
ATG9A-mediated autophagy prevents inflammatory skin disease by limiting TNFR1-driven STING activation and ZBP1-dependent cell death.
Journal: Immunity
Published: March 03, 2025
Enhancing anti-tumor immunity through intratumoral combination therapy with amphiphilic conjugates of oxaliplatin and imidazoquinoline TLR7/8 agonist.
Journal: RSC advances
Published: January 07, 2025
Last Updated: 09/26/2026